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CONCLUSION: BMP-2 is expressed in normal adult rat 
liver and negatively regulates hepatocyte proliferation. 
The observed down regulation of BMP-2 following partial 
hepatectomy suggests that such down regulation may be 
necessary for hepatocyte proliferation.
© 2006 The WJG Press. All rights reserved.
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INTRODUCTION
Bone morphogenetic proteins (BMPs) were first identified 
in the 1960s[1]. BMPs are multi-functional growth factors 
that belong to the transforming growth factor beta (TGF-β) 
superfamily[2]. Mature BMPs are 30-38 kDa proteins 
that utilize BMP receptors and intracellular SMADs 
to transduce their signals to regulate cell proliferation, 
differentiation, morphogenesis and apoptosis. The role 
of  BMPs in embryonic development and in postnatal 
and adult animals has been extensively studied in recent 
years. In addition to their well recognized role in bone 
physiology, BMPs are known to regulate the development 
and homeostasis of  other organs including the liver[3]. 
Previous research showed that a receptor for BMP-9 is 
expressed in the HepG2 liver tumor cells. HepG2 cells 
bind BMP-9 and undergo a proliferative response [4]. 
Northern blotting analysis demonstrated the presence 
of  BMP-6 in non-parenchymal liver cells and a role for 
BMP-6 in the regeneration of  liver tissue was proposed[5]. 
BMP signaling plays a critical role in the regulation of  liver 
development. BMP signaling from the septum transversum 
mesenchyme is necessary to induce liver genes in the 
endoderm and the morphogenetic growth of  the hepatic 
endoderm into a liver bud[6,7]. Similar to TGF-β signaling, 
BMP signaling has been implicated in the development 
of  hepatic fibrosis as BMPs have been shown to stimulate 
activation of  hepatic stellate cells, which results in their 
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Abstract
AIM: To characterize the expression and dynamic 
changes of bone morphogenetic protein (BMP)-2 in 
hepatocytes in the regenerating liver in rats after partial 
hepatectomy (PH), and examine the effects of BMP-2 on 
proliferation of human Huh7 hepatoma cells. 
METHODS: Fifty-four adult male Wistar rats were 
randomly divided into three groups: A normal control 
(NC) group, a partial hepatectomized (PH) group and 
a sham operated (SO) group. To study the effect of 
liver regeneration on BMP-2 expression, rats were 
sacrificed before and at different time points after PH 
or the sham intervention (6, 12, 24 and 48 h). For each 
time point, six rats were used in parallel. Expression 
and distribution of BMP-2 protein were determined 
in regenerating liver tissue by Western blot analysis 
and immunohistochemistry. Effects of BMP-2 on cell 
proliferation of human Huh7 hepatoma cell line were 
assessed using an MTT assay.
RESULTS: In the normal liver strong BMP-2 expression 
was observed around the central and portal veins. The 
expression of BMP-2 decreased rapidly as measured by 
both immunohistochemistry and Western blot analysis. 
This decrease was at a maximum of 3.22 fold after 12 
h and returned to normal levels at 48 h after PH. No 
significant changes in BMP-2 immunoreactivity were 
observed in the SO group. BMP-2 inhibited serum 
induced Huh7 cell proliferation. 
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transdifferentiation to an α-smooth muscle antigen 
positive myofibroblast-like phenotype[8,9].
Among BMPs, BMP-2 has gained more attention 
because it is the predominant form in natural bone 
morphogenetic protein extracts [10], and it is widely 
expressed during mouse development[11]. Researchers find 
that high affinity receptors for BMP-2 are present not 
only on osteoblastic cells but also on a large variety of  
non-hematopoietic cell types[12]. Preclinical and clinical 
studies have suggested that recombinant BMP-2 may have 
therapeutic potential in bone repair[13]. 
A hallmark of  developmental biology is that similar 
pathways are involved in multiple different systems. It is 
clear that the role of  BMP signaling is not restricted to 
the bone. The liver, just as the bone, has a remarkable 
regenerative potential, which involves tightly regulated 
molecular mechanisms that control hepatic proliferation, 
differentiation and morphogenesis after the loss of  hepatic 
tissue[14]. However, the role of  BMP signaling in the 
regenerating liver remains unclear. Here we focus on the 
expression and dynamic changes of  BMP-2 in hepatocytes 
in regenerating liver of  adult rats. 
MATERIALS AND METHODS
Experimental animals and grouping
Fifty-four adult and healthy male Wistar rats weighing 
180-220 g, obtained from the Animal Center of  Shanxi 
Medical University, were employed in the present study. 
All rats received humane care during the study under 
a protocol that was in accordance with institutional 
guidelines for animal research and was approved by 
the Ethics and Research Committee of  Shanxi Medical 
University. Experimental rats were randomly divided into 
three groups: Normal control (NC, n = 6) group, partial 
hepatectomized (PH, n = 24) group and sham operation 
(SO, n = 24) group. Rats were sacrificed at 6, 12, 24 and 48 
h after partial hepatectomy or sham operation. For each 
time point indicated, six rats (n = 6) were used in parallel.
Animal model and sample preparation
Rats were maintained on a 12/12 h light-dark cycle. 
The surgery was performed between 8 and 10 AM. Rats 
were fasted 12 h before surgery and anesthetized with 
pentobarbital sodium (30 mg/kg) intra-abdominally, then 
the abdominal skin was shaved and sterilized with an 
iodine solution. Two-thirds hepatectomy was performed 
as described by Higgins and Anderson. In the sham 
operated rats the liver was manipulated but not resected. 
Rats were anesthetized with pentobarbital sodium (20 
mg/kg) intra-abdominally and killed at 6, 12, 24 or 48 
h after partial hepatectomy or the sham procedure. The 
remnant livers were removed, parts of  which were fixed 
24 h in 10% buffered neutral formalin. The fixed livers 
were dehydrated through increasing concentrations of  
ethanol and in xylene and embedded in paraffin. Liver 
tissues embedded in paraffin were sectioned at 4 μm for 
immunohistochemistry. Part of  the livers was snap frozen 
in liquid nitrogen for the preparation of  protein lysates for 
Western blotting. 
Immunohistochemistry
Immunohistochemistry was performed as described in 
detail below. Paraffin sections (4 μm) were dewaxed and 
dehydrated in graded alcohols. Endogenous peroxidase 
activity was quenched with 1.5% H2O2 in PBS for 30 min 
at room temperature. Antigen retrieval was performed by 
heating for 10 min at 95℃ in 0.01 mol/L sodium citrate, 
and non-specific staining was blocked with TENG-T 
(10 mmol/L Tris, 5 mmol/L EDTA, 0.15 mol/L NaCl, 
0.25% gelatin, 0.05% [vol/vol] Tween-20, pH 8.0) for 30 
min at room temperature. Endogenous avidin binding 
activity due to biotin was overcome by successive 20 min 
incubations of  the tissue sections in 0.1% avidin and 0.01% 
biotin (DAKO Biotin Blocking System). After a washing 
with PBS (3 × 5 min), BMP-2 primary antibody (mouse 
monoclonal BMP-2, MAB355, 1:500, R&D) was applied 
in PBS containing 1% bovine serum albumin and 0.1% 
Triton and incubated overnight at 4℃. The following 
day, for BMP-2 staining, sections were incubated with 
biotinylated goat-anti-mouse IgG (DAKO 1:200) for 60 
min in PBS with 10% human serum, then washed in PBS 
(3 × 10 min) and incubated for 60 min with streptavidin-
biotin-horse-radish peroxidase (DAKO) for 1 h, and 
washed again 3 × 5 min in PBS. And peroxidase activity 
was detected with DAB (Sigma), resulting in the formation 
of  a brown reaction product. Finally, sections were 
briefly counterstained with hematoxylin, then dehydrated, 
cleared and mounted in neutral gum under cover slips. 
For controls, the primary and secondary antibodies were 
substituted and an appropriate IgG control (mouse IgG2b 
was applied at 1:50) was used to perform negative control 
staining. A known positive staining specimen (bone tissue 
of  rat) was used as a positive control.
Immunoblotting
Rat liver tissue was homogenized in lysis buffer. Protein 
concentrations were measured using the Bradford method. 
Lysates were diluted as per 300 μL protein sample buffer 
was added with 600 μg extract in 2 × protein sample 
buffer and 30 μL of  each sample of  homogenates was 
loaded per lane on an SDS-PAGE gel. Equal protein 
loading was confirmed using β-actin (Santa Cruz) 
antibodies on the same blots after stripping off  the old 
antibodies in stripping buffer. After protein separation the 
proteins were blotted onto a PVDF membrane (Millipore, 
Bedford, MA). The membranes were blocked with 2% 
protein (Nutricia, The Netherlands) in PBS supplemented 
with 0.1% Tween-20 for 1 h at room temperature. After 
a brief  wash in washing buffer (0.2% protifar: 0.1% 
Tween-20), membranes were incubated overnight at 
4℃ with primary antibody (mouse monoclonal BMP-2, 
MAB 355, 1:1000, R&D systems) in 2% blocking buffer. 
The following day, membranes were washed three times 
for 5 min, and subsequently incubated with a secondary 
horseradish peroxidase (HRP)-conjugated antibody in 
wash buffer (0.2% low fat milk powder) at 1:1000 dilution. 
After enhanced chemoluminescence using Lumilight + 
substrate (Roche, Mannheim, Germany), antibody binding 
was visualized using a Lumi-Image-Pro Plus 5.0.
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Cell culture and proliferation assay
The Huh7 human hepatoma cell line[15] was obtained 
from the ATCC (American Type Culture Collection) 
and cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM)(Gibco, Paisley, Scotland) with 4.5 g/L glucose 
and 1% L-glutamine. This was supplemented with 
penicillin (50 U/mL), streptomycin (50 μg/mL) and 
10% FBS (Gibco). Cells were grown in monolayers in a 
humidified atmosphere containing 5% CO2. Eighty to 
ninety percent confluent monolayers of  Huh7 cells were 
trypsinized and taken up in medium with 10% FBS. Cells at 
5 × 104 per well were seeded in triplicate in flat-bottomed 
tissue culture of  24 well plates (Falcon) overnight in 
DMEM medium containing 10% FBS in the absence 
or presence of  recombinant human BMP-2 (rhBMP-2 
355-BM, R&D systems) at indicated concentrations for 72 
h. MTT [3-(4,5-methylthiazol-2-yl)-2,5-dipheyl-tetrazolium 
bromide] reagent was added to all wells for 30 min. The 
medium was removed from the cells, and cells were lysed 
in acidic isopropanol and absorbance was measured at 
550 nm with an enzyme-linked immunosorbent assay 
plate reader (Molecular Devices, Ther/vio max microplate 
reader).
Statistical analysis
Values are expressed as mean ± SE. Results were evaluated 
using analysis of  variance and correlated by SPSS11.0 
software. P < 0.05 was considered significant.
RESULTS
Localization of BMP-2 expression in regenerating rat liver
To determine the expression and localization of  BMP-2 
in the regenerating rat liver, immunostaining was carried 
out using a specific monoclonal anti-BMP-2 antibody. 
As evident from Figure 1, clear and strong BMP-2 
immunoreactivity was present in the cytoplasm of  
hepatocytes around the central vein (CV) and portal triad 
(PT) in normal liver. In contrast, immunoreactivity of  
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Figure 2  Immunoblot for BMP-2 in rat liver of NC, SO and PH groups. At all 
the time points (note: 0 h = NC), rat liver extracts tested showed a band at 
approximately 37 kDa on the immunoblots. Bio-Rad Precision Protein Standards 
were used. Equal protein loading was confirmed using β-actin antibodies on the 
same blots by striping the old antibodies in strip buffer. The calculated molecular 
weights are shown. Quantification of 12 h immunoblots revealed 3.22 fold lower (P 
< 0.01) BMP-2 protein expression levels in PH group as compared with NC group. 





Figure 1  By immunohistochemistry, 
BMP-2 is expressed predominantly 
in hepatocytes around the 
central vein and portal triad. 
Strong BMP-2 staining is seen 
localized to the cytoplasm of NC 
group (A). The strong BMP-2 
staining seen in normal tissue 
is lost at 6,12 h group (B,C) 
and resumes at 48 h group (D) 
following PH. There was no 
significant change in SO group 
compared with NC group in 
BMP-2 immunoreactivity (data 
not shown). Control stainings 
were performed by omitting 
the primary antibody and using 
a control IgG2b that showed 
no staining. A known positive 
staining specimen was used 
as a positive control (data not 
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the immunoreactivity of  BMP-2 increased progressively 
and was back to normal levels at 48 h after PH. No 
significant change in BMP2 expression in SO group 
compared to normal controls was observed (data not 
shown).
Levels of BMP-2 in regenerating rat liver
To confirm the specificity of  the observed changes in 
BMP-2 expression in the regenerating rat liver, levels 
of  BMP-2 expression were determined by Western 
blot analysis. As shown in Figure 2, using the antibody 
a band at approximately 37 kDa was detected on the 
immunoblots, which corresponds to BMP-2 precursor 
protein. Quantification of  BMP-2 expression showed a 3.22 
fold reduction (P < 0.01) of  BMP-2 protein expression 
compared to controls at 12 h after PH. Similar to the 
results obtained by immunohistochemistry, BMP-2 protein 
levels returned to control levels at 48 h after PH. There 
were no significant changes in BMP-2 expression in the 
SO group compared to normal controls. 
Effects of BMP-2 on human hepatoma Huh7 cell line 
proliferation 
Because BMP-2 expression was down regulated during 
liver regeneration, we next attempted to determine whether 
BMP-2 was capable of  modulating Huh7 cell proliferation. 
To this end, Huh7 cells were treated with increasing 
concentrations of  rhBMP-2. MTT assay demonstrated that 
proliferation of  Huh7 cells was dose dependently inhibited 
by rhBMP-2. A maximal inhibition of  38.8% ± 0.4% (P < 
0.01) was observed at 100 ng/mL (Figure 3).
DISCUSSION
Following partial hepatectomy, there is a rapid and highly 
orchestrated series of  biochemical events that regulate 
hepatic regeneration. This is a complex process, which 
allows for a short period of  rapid cellular proliferation but 
is subsequently followed by cell cycle arrest and cellular 
differentiation[14]. It has been shown that BMP signaling 
plays a critical role in hepatogenesis during endodermal 
patterning[6]. However, the role of  BMPs in hepatic 
regeneration in the adult has not been studied. 
The present study analyzed the expression of  BMP-2 
in normal rat liver. We studied the changes in BMP-2 
expression during liver regeneration in the two-thirds 
hepatectomy model in rats. Immunohistochemical analysis 
showed that strong BMP-2 immunoreactivity was present 
in the cytoplasm of  normal rat hepatocytes surrounding 
CV and PT. Both immunohistochemistry and Western blot 
analysis showed that BMP-2 declined significantly at 12 
h after partial hepatectomy and returned to normal at 48 
h. We showed that BMP-2 suppressed growth of  Huh7 
hepatoma cells in vitro, suggesting that BMP signaling 
negatively regulates hepatocyte proliferation. However, this 
in vitro observation needs further confirmation in vivo in a 
model of  hepatocyte regeneration.
Our data remain descriptive but suggest that the role of  
signaling by BMP-2 may be distinct from that of  TGF-β1, 
another TGF-β family member that signals through a 
different receptor complex. TGF-β1 is also an inhibitor 
of  hepatocyte proliferation[16]; however, the normal liver 
expresses very low levels of  TGF-β1. Levels of  TGF-β1 
expression increase rapidly after partial hepatectomy and 
peak at 12 h[17] exactly when the expression of  BMP-2 
is at its lowest. In mice with a liver specific deletion of  
TGF-β receptor type II, which is required for TGF-β 
signaling, increased hepatocyte proliferation and liver 
mass in response to partial hepatectomy was resulted[18], 
indicating that TGF-β signaling acts as a negative feedback 
loop in hepatic regeneration that keeps the mitogenic 
response in check. The dynamic expression of  BMP-2 
suggests a distinct role for this pathway. BMP-2 is readily 
detected in the normal liver and its expression rapidly 
declines after partial hepatectomy. This may suggest that 
BMP-2 signaling does not act in a negative feedback 
loop in hepatocyte regeneration but that instead, its 
down regulation may be necessary for the initiation 
of  hepatocyte proliferation. Hepatocytes are the first 
to proliferate after partial hepatectomy. Hepatocyte 
proliferation started exactly in the area around the CV 
where BMP-2 expression was lost well before the onset of  
proliferation which peaked at 24 h[19]. 
In conclusion, both the localization and timing of  
expression of  BMP-2 suggest that BMP-2 may be a 
negative regulator of  hepatocyte proliferation that needs 
to be down regulated in order to allow the initiation 
of  hepatocyte proliferation around the CV. Our data 
remain descriptive and interventional studies need to be 
performed to test this hypothesis.
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molecular mechanisms that control hepatic proliferation, differentiation and 
morphogenesis after the loss of hepatic tissue.
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